Context Therapeutics is trading 5.26% down at $0.50 amid broader market weakness, with the Nasdaq Composite down 1.32% and the S&P 500 down 0.58%.
- No fresh company-specific announcement dated August 18, 2026 was found.
- The latest company update was its August 5 second-quarter report and pipeline update.
- An August 18 repost discussed that earlier presentation rather than a new catalyst.